1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEPentoxifyllineCat. No.: HY-B0715CAS No.: 6493-05-6Synonyms: BL-191; PTX; Oxpentifylline分式: CHNO分量: 278.31作靶点: Phosphodiesterase (PDE); Autophagy作通路: Metabolic Enzyme/Protease; Autophagy储存式: -20C 3 yearsPowder4C 2 years-80C 6 mon
2、thsIn solvent-20C 1 month溶解性数据体外实验 H2O : 93.3 mg/mL (335.24 mM; Need ultrasonic and warming)DMSO : 2.8 mg/mL (10.06 mM)* “ means soluble, but saturation unknown.MassSolventConcentration1 mg 5 mg 10 mg1 mM 3.5931 mL 17.9656 mL 35.9312 mL5 mM 0.7186 mL 3.5931 mL 7.1862 mL10 mM 0.3593 mL 1.7966 mL 3.59
3、31 mL制备储备液请根据产品在不同溶剂中的溶解度，选择合适的溶剂配制储备液，并请注意储备液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Pentoxifylline是竞争性选择性磷酸酯酶（ PDE） 抑制剂。客户使本产品发表的科研献1/2 Master of Small Molecules 您边的抑制剂师www.MedChemE Prostate. 2019 Feb 3. See more customer validations on www.MedChemEREFERENCES1. http:/en.wikipedia.org/wiki/Pentoxifylline2.
4、Salhiyyah, K., et al., Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev, 2012. 1: p. CD005262.3. Li, W., et al., Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease. Lipids Health Dis, 2011. 10: p. 49.McePdfHeightCaution: Product has not been fully validated for medical applications. For research use only.Tel: 400-820-3792; 021-58955995 Fax: 021-53700325 E-mail: techMedChemE2/2 Master of Small Molecules 您边的抑制剂师
个人主页
